Brind.

Journey Medical Corporation, founded by Fortress Biotech, is located in Scottsdale and sells FDA-approved products while filing reports with the SEC.

8 reports, 4 independent Updated Aug 14
Gone quiet Reached 2 outlets in its first 24 hours
Reports
8
Developments
3
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Journey Medical Corporation, founded by Fortress Biotech, is located in Scottsdale and sells FDA-approved products while filing reports with the SEC.

Who's involved

What this event is mainly about
Fortress BiotechFDA

How it developed

Newest first. Tap a step to see who reported it.
  1. Journey Medical Corporation expanded payer coverage supporting the adoption of Emrosi.Sub-event
  2. Journey Medical, based in Scottsdale, sells FDA-approved products and files SEC reports.1 source
  3. Journey Medical Corporation outperformed the S&P 500 this year and operates in the Medical Drugs industry.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • manilatimes.net
  • themarketsdaily.com
  • GlobeNewswireJourney Medical Corporation to Participate in September 2025 Investor Conferences SCOTTSDALE, Ariz., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”
  • GlobeNewswireJourney Medical Corporation to Present at the Emerging Growth Conference SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Compa
  • GlobeNewswireJourney Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Second quarter 2025 revenues were $15.0 million Emrosi™ net sales of $2.8 million generated i
  • ZacksJourney Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates Journey Medical Corporation (DERM) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of
  • GlobeNewswireJourney Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or
1 more outlet ran the same wire story